Skip to main content
. Author manuscript; available in PMC: 2016 Apr 1.
Published in final edited form as: Gastrointest Endosc. 2014 Dec 12;81(4):943–949.e1. doi: 10.1016/j.gie.2014.09.041

Figure 2.

Figure 2

Figure demonstrates the box-plot of the various volatile organic compounds (panels A–D) in patients with cholangiocarcinoma (CCA) and primary sclerosing cholangitis (PSC)